Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives
Open Access
- 1 July 1997
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 242, 63-67
- https://doi.org/10.1111/joim.1997.242.s740.63
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemiaThe Lancet, 1996
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1995
- Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders [published erratum appears in Blood 1996 Mar 1;87(5):2093]Blood, 1995
- Infectious and immunosuppressive complications of purine analog therapy.Journal of Clinical Oncology, 1995
- 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia.Journal of Clinical Oncology, 1995
- Chronic lymphocytic leukaemia treatmentBlood Reviews, 1993
- Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.Journal of Clinical Pathology, 1989
- Chronic Lymphocytic Leukemia: Recommendations for Diagnosis, Staging, and Response CriteriaAnnals of Internal Medicine, 1989
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981
- Clinical staging of chronic lymphocytic leukemiaBlood, 1975